把三张表、经营指标、SEC / 巨潮 / 港交所原始财报、业绩材料和电话会放到同一条可核验时间线上。 披露事实、结构化补位值与派生指标分开标注,缺失逐字稿不会用摘要或模型生成内容补齐。
单季、累计、年度和资产负债表时点分开保存;每个数值都保留单位、申报日、表单、XBRL 概念或原始中文字段。
美股链接 SEC 法定申报和发行人 IR,A 股链接巨潮原始 PDF,港股链接港交所披露易原始年报与中报。分部、订单、产能和客户集中度只在有可核验披露时展示。
官方电话会入口与已授权逐字稿分开。没有合法取得的全文时只显示材料可用性,不生成或拼接虚假的逐字稿。
三张表会执行资产负债、毛利润、税前利润等勾稽检查;超出容差的记录保留原值并标记警告, 不会为了让公式“对上”而修改公司披露。
| 2026-04-30 |
| 3/3 |
| $1.74B |
| $367.77M |
| $321.8M |
| 76.1% |
| -1.9% |
| 70 |
| 尚无授权文本 |
| LAKE LAKELAND INDUSTRIES INC | 2026-04-30 | 3/3 | $47.42M | $369,000 | $4.41M | 31.4% | 4.8% | 113 | 尚无授权文本 |
| ALIT Alight, Inc. / Delaware | 2026-03-31 | 3/3 | $534M | -$19M | $53M | 29.2% | -4.1% | 104 | 尚无授权文本 |
| CE Celanese Corp | 2026-03-31 | 3/3 | $2.34B | $44M | $10M | 20.0% | 9.2% | 138 | 尚无授权文本 |
| ELA Envela Corp | 2026-03-31 | 3/3 | $98.38M | $8.84M | $20.59M | 21.0% | 11.4% | 40 | 尚无授权文本 |
| ELAB PMGC Holdings Inc. | 2026-03-31 | 3/3 | $681,994 | -$4.97M | -$3.34M | 33.8% | — | 106 | 尚无授权文本 |
| ELAN Elanco Animal Health Inc | 2026-03-31 | 3/3 | $1.37B | $57M | -$38M | 57.3% | — | 103 | 尚无授权文本 |
| ELWT Elauwit Connection, Inc. | 2026-03-31 | 3/3 | $4.43M | -$2.16M | — | 18.7% | -49.7% | 13 | 尚无授权文本 |
| LKFN LAKELAND FINANCIAL CORP | 2026-03-31 | 3/3 | — | $26.48M | $29.95M | — | — | 114 | 尚无授权文本 |
| MACI Melar Acquisition Corp. I/Cayman | 2026-03-31 | 3/3 | — | $778,261 | — | — | — | 26 | 尚无授权文本 |
| MACIU Melar Acquisition Corp. I/Cayman | 2026-03-31 | 3/3 | — | $778,261 | — | — | — | 26 | 尚无授权文本 |
| PLGO Pelagos Insurance Capital Ltd | 2026-03-31 | 3/3 | $610.6M | $108M | — | — | — | 52 | 尚无授权文本 |
| REVB REVELATION BIOSCIENCES, INC. | 2026-03-31 | 3/3 | — | -$3.01M | -$3.29M | — | — | 117 | 尚无授权文本 |
| RLAY Relay Therapeutics, Inc. | 2026-03-31 | 3/3 | $3M | -$73.29M | — | — | -2619.7% | 85 | 尚无授权文本 |
| TELA TELA Bio, Inc. | 2026-03-31 | 3/3 | $19.06M | -$12.27M | -$11.29M | 65.7% | -55.2% | 93 | 尚无授权文本 |
| PCLA PicoCELA Inc. | 2025-09-30 | 3/3 | $544.69M | -$626.31M | -$572.36M | — | -110.4% | 22 | 尚无授权文本 |
| VLRS Controladora Vuela Compania de Aviacion, S.A.B. de C.V. | 2024-12-31 | 2/3 | — | $126.38M | — | — | — | 165 | 尚无授权文本 |